ICMR School of Public Health, ICMR-National Institute of Epidemiology, Chennai, India.
Institute of Public Health, Charité-UniversitätMedizin, Berlin, Germany.
JCO Glob Oncol. 2023 Mar;9:e2200401. doi: 10.1200/GO.22.00401.
In the light of WHO's call for elimination of cervical cancer, primary human papillomavirus (HPV) screening through self-collection is a powerful tool that can improve screening coverage. Challenges encountered during implementation of the program are unique to each country. We conducted this systematic review to list the challenges in implementing primary HPV screening through self-sampling in Indian context.
A literature search was performed in PubMed, Embase, and Google Scholar since their inception till July 2022 for peer-reviewed articles published in the English. Non-Indian studies and those which did not mention implementation challenges were excluded. Articles were screened and reviewed independently by two authors. The results were discussed using a narrative synthesis.
All the eight original articles included in the review were of cross-sectional design. The challenges identified in these studies were grouped into beneficiary, health care provider, and health system perspectives. Beneficiary-related issues outnumbered other challenges in all the studies which included misconceptions and fear, lack of motivation, low self-efficacy in collection leading to poor sample quality, low socioeconomic status leading to lack of privacy, and refusal for screening and further treatment.
This review highlights the challenges for the implementation of HPV self-sampling in India. Future programs should incorporate context-specific solutions for the success of primary HPV screening and cervical cancer elimination.
鉴于世界卫生组织呼吁消除宫颈癌,通过自我采集进行初级人乳头瘤病毒(HPV)筛查是一种可以提高筛查覆盖率的有力工具。实施该计划所遇到的挑战在每个国家都是独特的。我们进行了这项系统评价,以列出在印度实施初级 HPV 自我采样筛查时所面临的挑战。
从成立之初到 2022 年 7 月,我们在 PubMed、Embase 和 Google Scholar 上进行了文献检索,以查找发表在英文期刊上的同行评审文章。我们排除了非印度研究和未提及实施挑战的文章。两位作者独立筛选和审查了文章。使用叙述性综合法对结果进行了讨论。
综述中纳入的所有 8 篇原始文章均为横断面设计。这些研究中确定的挑战分为受益人和医疗保健提供者以及卫生系统三个角度。在所有研究中,与其他挑战相比,与受益人的相关问题更为突出,这些问题包括误解和恐惧、缺乏动机、采集样本时自我效能感低导致样本质量差、低社会经济地位导致缺乏隐私以及拒绝筛查和进一步治疗。
本综述强调了在印度实施 HPV 自我采样所面临的挑战。未来的项目应针对初级 HPV 筛查和宫颈癌消除的成功制定特定于国情的解决方案。